Free tool
Oncology stocks
We cover 1 company grouped under the Oncology theme. The median market value in the group is $42.82M. Across the group, the median move over the past trading day is +1.18%. Price change over the past year runs from −36.8% to −36.8% across the middle 80 percent of the group, with a median of −36.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 319 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.76% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.